http://orcid.org/0000-0003-4583-3818
About the Authors
- Samantha Yuille
-
Roles Conceptualization, Formal analysis, Investigation, Methodology, Validation, Writing – original draft, Writing – review & editing
Affiliation 4DPharma Research Ltd., Aberdeen, United Kingdom
- Nicole Reichardt
-
Roles Data curation, Formal analysis, Project administration, Supervision, Visualization, Writing – original draft, Writing – review & editing
Affiliation 4DPharma Research Ltd., Aberdeen, United Kingdom
- Suchita Panda
-
Roles Formal analysis, Investigation, Methodology, Validation, Writing – original draft, Writing – review & editing
Affiliation 4DPharma Research Ltd., Aberdeen, United Kingdom
- Hayley Dunbar
-
Roles Investigation, Validation
Affiliation 4DPharma Research Ltd., Aberdeen, United Kingdom
- Imke E. Mulder
-
Roles Conceptualization, Project administration, Supervision, Writing – review & editing
* E-mail: imke.mulder@4dpharmaplc.com
Affiliation 4DPharma Research Ltd., Aberdeen, United Kingdom
Competing Interests
The authors would like to declare the following competing interests: SY, NR, HD, SP, IEM are affiliated with and received funding for this study from 4D Pharma Research Ltd. The strains reported herein as being of therapeutic potential and their use in therapy are the subject of pending International Patent Application No. PCT/EP2018/065858, European Patent Application Nos. 18178136.0, 18179641.8, 18179634.3 and 18171893.3 and UK Patent Application No. 1810386.1, all of which are currently unpublished. The simulated microbiome system is the subject of pending European Patent Application No. 18170880.1, which is currently unpublished. This does not alter our adherence to PLOS ONE policies on sharing data and materials.